Global pharmaceutical pioneer with executive commercial, market access, and government affairs experience across large and small companies with therapeutic expertise in leading organizations specializing in oncology, rare and ultra-rare diseases, and other specialty areas. Vast experience preparing, completing, and implementing mergers and acquisitions of companies and assets. Accomplished strategist and operational leader from both executive and board perspective. Served as General Manager with cross functional P&L accountability in several countries including Canada, USA, LATAM and Nordics. Sought-after industry thought leader and keynote speaker known for engaging industry peers, customers, governments, investors and employees worldwide. Elected and appointed to board positions in publicly traded and private companies as well as not-for-profit organizations. Fluently bilingual in English and French.
"Rare Leadership: Women Redefining Healthcare," assembles five distinguished leaders, four of which were featured on the Healthcare Marketing Sherpas Podcast: Rare Women Series, with host Janet Carlson, launched in April, 2025. Each of these women has and continues to pioneer change to improve healthcare and address critical rare disease and biopharma needs. They are united by a commitment to innovative therapies, patient-centered care, and sustainable healthcare solutions. Their backgrounds are diverse, with expertise in healthcare, biopharma, and biotech. They have unique perspectives on resolving rare disease challenges and improving healthcare for underserved communities. Their personal stories and professional insights will inspire others to shape the healthcare of tomorrow.
We’ll discuss: